OS
Highly rated in
14
conditions
Highly rated in
14
conditions

About Dr. Olivier Sterkers

Olivier Sterkers is in Paris, France. Dr. Sterkers is highly rated in 14 conditions, according to our data. His top areas of expertise are Hearing Loss, Acoustic Neuroma, Schwannoma, and Familial Otosclerosis.

His clinical research consists of co-authoring 170 peer reviewed articles and participating in 8 clinical trials in the past 15 years.

Locations
  Paris, FR
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials


170 Total Publications

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Published —March 12, 2021
Radiological and Audiological Outcomes of the LISTENT LCI-20PI Cochlear Implant Device.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Necker Enfants Malades Hospital
 
Paris, FR 75006
 0.1 km
Rima Nabbout is in Paris, France. They have been an author on 213 peer reviewed articles and participated in 2 clinical trials in the past 15 years.
Highly rated in
0
conditions
Assistance Publique Hôpitaux De Paris
 
Paris, FR 
 0.1 km
Benjamin Terrier is in Paris, France. They have been an author on 252 peer reviewed articles and participated in 9 clinical trials in the past 15 years.
Highly rated in
0
conditions
University Of Oxford
 
Paris, FR 
 0.1 km
Laurent Servais is in Paris, France. They have been an author on 116 peer reviewed articles and participated in 22 clinical trials in the past 15 years.